Patient Preference and Visual Quality with Contralateral +3.25 TMF versus Panoptix Trifocal
Research payments
$198,390
Through program year 2022, $198,390 in research payments was reported against Patient Preference and Visual Quality with Contralateral +3.25 TMF versus Panoptix Trifocal, across 13 payments, paid by Johnson & Johnson Surgical Vision, Inc..
- Paid by
- Johnson & Johnson Surgical Vision, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $37,920 | 3 |
| 2021 | Research | $55,470 | 4 |
| 2020 | Research | $105,000 | 6 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
1 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.